Lausanne, Switzerland

Pierre-Alain Bionda

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Ferton Holding S.a.. Active years: 2022.


% Patents Active = 100.0


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Pierre-Alain Bionda: Innovator in Medical Device Technology

Introduction

Pierre-Alain Bionda is a notable inventor based in Lausanne, Switzerland. He has made significant contributions to the field of medical devices, particularly in the area of calculus fragmentation. His innovative approach has led to the development of a unique device that enhances the efficiency of medical procedures.

Latest Patents

Bionda holds a patent for a "Device and method for the fragmentation of a calculus." This device includes a probe and a drive unit designed to deflect the probe along its longitudinal extension. The drive unit features a first drive element for periodically deflecting the probe and a second drive element for pulsed deflection. Notably, the design allows for the superimposition of periodic and pulsed deflections, which enhances the device's functionality.

Career Highlights

Pierre-Alain Bionda is associated with Ferton Holding S.A., where he continues to innovate in the medical device sector. His work has been instrumental in advancing techniques used in medical procedures, particularly those involving calculus fragmentation.

Collaborations

Bionda has collaborated with notable professionals in his field, including Jean-Yves Girod and Gary Evans. These partnerships have contributed to the development and refinement of his innovative medical devices.

Conclusion

Pierre-Alain Bionda's contributions to medical technology through his patented inventions demonstrate his commitment to improving healthcare solutions. His work continues to influence the field positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…